Saving changes...



Virus-based Therapies for Canine Cancer

Virus-based Therapies for Canine Cancer

Virus-based Therapies for Canine Cancer

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association


$25.00 $ 25.00 $ 25.00

25.00 $ 25.00 25.00 25.00
Normal Price: FREE $25.00


Launch date: 16 Apr 2015
Expiry Date:

Last updated: 30 Aug 2020

Reference: 150808

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.


Adenoviral vectors (Ad) have been employed for anti-cancer applications. These applications have included gene therapy, virotherapy and vaccinology. Canine subjects have been employed as models of virus-based interventions that have allowed stringent address of key biologic issues. In addition, primary therapies for canine cancers have derived from these studies.


We have sought to adapt adenovirus for cancer therapy applications. In this regard, we have exploited adenovirus as a gene delivery vector for gene therapy, as a conditionally replicative virus for virotherapy and as a vaccine agent for immunotherapy. Critical to full development of such adenovirus-based interventions for cancer has been the requirement for validation in stringent model systems. To this end, we have capitalized in the availability of canine cancer contexts to establish the effec
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

Dr. David Curiel, M.D., Ph.D. is the Director of the Cancer Biology Division of the Department of Radiation Oncology at Washington University School of Medicine. Dr. Curiel graduated medical school at Emory University in 1982, where he also completed his internship and residency in Internal Medicine. Dr. Curiel’s scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990. He received his Ph.D. from University of Groningen in The Netherlands in 2002. Dr. Curiel has been at Washington University School of Medicine since 2011. In addition to his role as Director of the Cancer Biology Division, he is Director of the Biologic Therapeutics Center.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 1.00 Hours -
    Exam Attempts: 3
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:


User Reviews (0)

Go Back


Saving changes...